Edition:
United Kingdom

North China Pharmaceutical Co Ltd (600812.SS)

600812.SS on Shanghai Stock Exchange

5.14CNY
13 Dec 2017
Change (% chg)

¥0.04 (+0.78%)
Prev Close
¥5.10
Open
¥5.08
Day's High
¥5.15
Day's Low
¥5.08
Volume
1,676,604
Avg. Vol
4,508,451
52-wk High
¥7.60
52-wk Low
¥4.96

Chart for

About

North China Pharmaceutical Company. Ltd is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company's main products are classified as penicillin, cephalosporin, vitamin and other products, including bulk pharmaceuticals, finish preparations and healthcare products, among... (more)
No analyst recommendations are available for .

Overall

Beta: 1.00
Market Cap(Mil.): ¥9,458.67
Shares Outstanding(Mil.): 1,630.81
Dividend: 0.02
Yield (%): 0.34

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-North China Pharmaceutical to issue up to 2 bln yuan commercial paper

* Says it plans to issue up to 2.0 billion yuan ($302.20 million) commercial paper

20 Oct 2017

BRIEF-North China Pharmaceutical issues 2017 second tranche corporate bonds worth 290 mln yuan

* Says it issued 2017 second tranche corporate bonds worth 290 million yuan

28 Sep 2017

BRIEF-North China Pharmaceutical sets coupon rate of 2017 2st tranche corporate bonds at 6.2 pct

* Says it sets coupon rate of 2017 2st tranche corporate bonds at 6.2 percent

26 Sep 2017

BRIEF-North China Pharmaceutical to issue 290 mln yuan 4-year bonds

* Says to issue 290 million yuan ($43.97 million) 4-year bonds

21 Sep 2017

BRIEF-North China Pharmaceutical to pay A shares annual div for FY 2016 on Aug. 25

* Says it will pay cash dividend of 0.02 yuan(before tax)/share for 2016 to shareholders of record on Aug. 24

21 Aug 2017

BRIEF-North China Pharmaceutical issues 2017 2nd series super short-term debentures worth 500 mln yuan

* Says it issues 2017 the second series super short-term debentures worth 500 million yuan, with coupon rate of 5.08 percent and maturity date on Jan. 29, 2018

03 Aug 2017

BRIEF-North China Pharmaceutical issues 210 mln yuan worth of corporate bonds

* Says it issues 210 mln yuan worth of 2017 public offering corporate bonds

02 Aug 2017

BRIEF-North China Pharmaceutical sets coupon rate for 2017 corporate bonds at 6.5 pct

* Says it sets coupon rate for 2017 corporate bonds at 6.5 percent

31 Jul 2017

BRIEF-North China Pharmaceutical to issue up to 500 mln yuan 4-year bonds

* Says to issue up to 500 million yuan ($74.10 million) 4-year bonds

25 Jul 2017

BRIEF-North China Pharmaceutical's unit receives GMP certificate

* Says co's pharmacy unit received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration, for its sterile APIs (amoxicillin/sulbactam), with the valid period is until June 22, 2022

18 Jul 2017

Earnings vs. Estimates